Table of Contents 1 Prostate Cancer Therapeutic Market Overview 1.1 Product Overview and Scope of Prostate Cancer Therapeutic 1.2 Prostate Cancer Therapeutic Segment by Type 1.2.1 Global Prostate Cancer Therapeutic Production and CAGR (%) Comparison by Type (2014-2026) 1.2.2 The Market Profile of Type 1 1.2.3 The Market Profile of Type 2 1.2.4 The Market Profile of Type 3 1.3 Global Prostate Cancer Therapeutic Segment by Application 1.3.1 Prostate Cancer Therapeutic Consumption (Sales) Comparison by Application (2014-2026) 1.3.2 The Market Profile of Application 1 1.3.3 The Market Profile of Application 2 1.3.4 The Market Profile of Application 3 1.4 Global Prostate Cancer Therapeutic Market by Region (2014-2026) 1.4.1 Global Prostate Cancer Therapeutic Market Size (Value) and CAGR (%) Comparison by Region (2014-2026) 1.4.2 United States Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3 Europe Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.1 Germany Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.2 UK Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.3 France Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.4 Italy Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.5 Spain Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.6 Russia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.3.7 Poland Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.4 China Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.5 Japan Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.6 India Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7 Southeast Asia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.1 Malaysia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.2 Singapore Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.3 Philippines Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.4 Indonesia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.5 Thailand Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.7.6 Vietnam Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.8 Central and South America Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.8.1 Brazil Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.8.2 Mexico Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.8.3 Colombia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9 Middle East and Africa Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.1 Saudi Arabia Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.2 United Arab Emirates Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.3 Turkey Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.4 Egypt Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.5 South Africa Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.4.9.6 Nigeria Prostate Cancer Therapeutic Market Status and Prospect (2014-2026) 1.5 Global Market Size (Value) of Prostate Cancer Therapeutic (2014-2026) 1.5.1 Global Prostate Cancer Therapeutic Revenue Status and Outlook (2014-2026) 1.5.2 Global Prostate Cancer Therapeutic Production Status and Outlook (2014-2026) 2 Global Prostate Cancer Therapeutic Market Landscape by Player 2.1 Global Prostate Cancer Therapeutic Production and Share by Player (2014-2019) 2.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Player (2014-2019) 2.3 Global Prostate Cancer Therapeutic Average Price by Player (2014-2019) 2.4 Prostate Cancer Therapeutic Manufacturing Base Distribution, Sales Area and Product Type by Player 2.5 Prostate Cancer Therapeutic Market Competitive Situation and Trends 2.5.1 Prostate Cancer Therapeutic Market Concentration Rate 2.5.2 Prostate Cancer Therapeutic Market Share of Top 3 and Top 6 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Players Profiles 3.1 OSI Pharmaceuticals, Inc. (USA) 3.1.1 OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.1.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.1.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.1.4 OSI Pharmaceuticals, Inc. (USA) Business Overview 3.2 Bristol-Myers Squibb Company (USA) 3.2.1 Bristol-Myers Squibb Company (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.2.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.2.3 Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.2.4 Bristol-Myers Squibb Company (USA) Business Overview 3.3 Novartis AG (Switzerland) 3.3.1 Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors 3.3.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.3.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.3.4 Novartis AG (Switzerland) Business Overview 3.4 GlaxoSmithKline Plc (UK) 3.4.1 GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Competitors 3.4.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.4.4 GlaxoSmithKline Plc (UK) Business Overview 3.5 Indevus Pharmaceuticals Inc. (USA) 3.5.1 Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.5.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.5.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.5.4 Indevus Pharmaceuticals Inc. (USA) Business Overview 3.6 Paladin Labs Inc. (Canada) 3.6.1 Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Competitors 3.6.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.6.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.6.4 Paladin Labs Inc. (Canada) Business Overview 3.7 Cell Genesys Inc. (USA) 3.7.1 Cell Genesys Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.7.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.7.3 Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.7.4 Cell Genesys Inc. (USA) Business Overview 3.8 Abbott Laboratories (USA) 3.8.1 Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.8.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.8.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.8.4 Abbott Laboratories (USA) Business Overview 3.9 Sanofi-Aventis SA (France) 3.9.1 Sanofi-Aventis SA (France) Basic Information, Manufacturing Base, Sales Area and Competitors 3.9.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.9.3 Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.9.4 Sanofi-Aventis SA (France) Business Overview 3.10 Pfizer Inc. (USA) 3.10.1 Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.10.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.10.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.10.4 Pfizer Inc. (USA) Business Overview 3.11 Immunomedics, Inc. (USA) 3.11.1 Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.11.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.11.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.11.4 Immunomedics, Inc. (USA) Business Overview 3.12 Genentech Inc. (USA) 3.12.1 Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.12.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.12.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.12.4 Genentech Inc. (USA) Business Overview 3.13 Progenics Pharmaceuticals, Inc. (USA) 3.13.1 Progenics Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.13.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.13.3 Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.13.4 Progenics Pharmaceuticals, Inc. (USA) Business Overview 3.14 ALZA Corporation (USA) 3.14.1 ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.14.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.14.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.14.4 ALZA Corporation (USA) Business Overview 3.15 Takeda Pharmaceutical Company Limited (Japan) 3.15.1 Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors 3.15.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.15.3 Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.15.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview 3.16 F. Hoffmann-La Roche Ltd. (Switzerland) 3.16.1 F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors 3.16.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.16.3 F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.16.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview 3.17 Medimmune, LLC (USA) 3.17.1 Medimmune, LLC (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.17.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.17.3 Medimmune, LLC (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.17.4 Medimmune, LLC (USA) Business Overview 3.18 EUSA Pharma, (USA) Inc. (USA) 3.18.1 EUSA Pharma, (USA) Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.18.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.18.3 EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.18.4 EUSA Pharma, (USA) Inc. (USA) Business Overview 3.19 AstraZeneca PLC (UK) 3.19.1 AstraZeneca PLC (UK) Basic Information, Manufacturing Base, Sales Area and Competitors 3.19.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.19.3 AstraZeneca PLC (UK) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.19.4 AstraZeneca PLC (UK) Business Overview 3.20 Amgen Inc. (USA) 3.20.1 Amgen Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.20.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.20.3 Amgen Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.20.4 Amgen Inc. (USA) Business Overview 3.21 Dendreon Corporation (USA) 3.21.1 Dendreon Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.21.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.21.3 Dendreon Corporation (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.21.4 Dendreon Corporation (USA) Business Overview 3.22 Spectrum Pharmaceuticals, Inc. (USA) 3.22.1 Spectrum Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors 3.22.2 Prostate Cancer Therapeutic Product Profiles, Application and Specification 3.22.3 Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Market Performance (2014-2019) 3.22.4 Spectrum Pharmaceuticals, Inc. (USA) Business Overview 4 Global Prostate Cancer Therapeutic Production, Revenue (Value), Price Trend by Type 4.1 Global Prostate Cancer Therapeutic Production and Market Share by Type (2014-2019) 4.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2014-2019) 4.3 Global Prostate Cancer Therapeutic Price by Type (2014-2019) 4.4 Global Prostate Cancer Therapeutic Production Growth Rate by Type (2014-2019) 4.4.1 Global Prostate Cancer Therapeutic Production Growth Rate of Type 1 (2014-2019) 4.4.2 Global Prostate Cancer Therapeutic Production Growth Rate of Type 2 (2014-2019) 4.4.3 Global Prostate Cancer Therapeutic Production Growth Rate of Type 3 (2014-2019) 5 Global Prostate Cancer Therapeutic Market Analysis by Application 5.1 Global Prostate Cancer Therapeutic Consumption and Market Share by Application (2014-2019) 5.2 Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2014-2019) 5.2.1 Global Prostate Cancer Therapeutic Consumption Growth Rate of Application 1 (2014-2019) 5.2.2 Global Prostate Cancer Therapeutic Consumption Growth Rate of Application 2 (2014-2019) 5.2.3 Global Prostate Cancer Therapeutic Consumption Growth Rate of Application 3 (2014-2019) 6 Global Prostate Cancer Therapeutic Production, Consumption, Export, Import by Region (2014-2019) 6.1 Global Prostate Cancer Therapeutic Consumption by Region (2014-2019) 6.2 United States Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.3 Europe Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.4 China Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.5 Japan Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.6 India Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.7 Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.8 Central and South America Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 6.9 Middle East and Africa Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) 7 Global Prostate Cancer Therapeutic Production, Revenue (Value) by Region (2014-2019) 7.1 Global Prostate Cancer Therapeutic Production and Market Share by Region (2014-2019) 7.2 Global Prostate Cancer Therapeutic Revenue (Value) and Market Share by Region (2014-2019) 7.3 Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.4 United States Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.5 Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.6 China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.7 Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.8 India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.9 Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.10 Central and South America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 7.11 Middle East and Africa Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) 8 Prostate Cancer Therapeutic Manufacturing Analysis 8.1 Prostate Cancer Therapeutic Key Raw Materials Analysis 8.1.1 Key Raw Materials Introduction 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Manufacturing Cost Analysis 8.2.1 Labor Cost Analysis 8.2.2 Manufacturing Cost Structure Analysis 8.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 9.1 Prostate Cancer Therapeutic Industrial Chain Analysis 9.2 Raw Materials Sources of Prostate Cancer Therapeutic Major Players in 2018 9.3 Downstream Buyers 10 Market Dynamics 10.1 Drivers 10.2 Restraints 10.3 Opportunities 10.3.1 Advances in Innovation and Technology for Prostate Cancer Therapeutic 10.3.2 Increased Demand in Emerging Markets 10.4 Challenges 10.4.1 The Performance of Alternative Product Type is Getting Better and Better 10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices 10.5 Porter’s Five Forces Analysis 10.5.1 Threat of New Entrants 10.5.2 Threat of Substitutes 10.5.3 Bargaining Power of Suppliers 10.5.4 Bargaining Power of Buyers 10.5.5 Intensity of Competitive Rivalry 11 Global Prostate Cancer Therapeutic Market Forecast (2019-2026) 11.1 Global Prostate Cancer Therapeutic Production, Revenue Forecast (2019-2026) 11.1.1 Global Prostate Cancer Therapeutic Production and Growth Rate Forecast (2019-2026) 11.1.2 Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2019-2026) 11.1.3 Global Prostate Cancer Therapeutic Price and Trend Forecast (2019-2026) 11.2 Global Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast by Region (2019-2026) 11.2.1 United States Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.2 Europe Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.3 China Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.4 Japan Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.5 India Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.6 Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.7 Central and South America Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.2.8 Middle East and Africa Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) 11.3 Global Prostate Cancer Therapeutic Production, Revenue and Price Forecast by Type (2019-2026) 11.4 Global Prostate Cancer Therapeutic Consumption Forecast by Application (2019-2026) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Research Data Source

List of Tables and Figures Figure Prostate Cancer Therapeutic Product Picture Table Global Prostate Cancer Therapeutic Production and CAGR (%) Comparison by Type Table Profile of Type 1 Table Profile of Type 2 Table Profile of Type 3 Table Prostate Cancer Therapeutic Consumption (Sales) Comparison by Application (2014-2026) Table Profile of Application 1 Table Profile of Application 2 Table Profile of Application 3 Figure Global Prostate Cancer Therapeutic Market Size (Value) and CAGR (%) (2014-2026) Figure United States Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Germany Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure UK Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure France Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Italy Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Spain Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Russia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Poland Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure China Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure India Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Malaysia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Singapore Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Philippines Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Indonesia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Thailand Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Vietnam Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Central and South America Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Brazil Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Mexico Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Colombia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Middle East and Africa Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Saudi Arabia Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure United Arab Emirates Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Turkey Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Egypt Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure South Africa Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Nigeria Prostate Cancer Therapeutic Revenue and Growth Rate (2014-2026) Figure Global Prostate Cancer Therapeutic Production Status and Outlook (2014-2026) Table Global Prostate Cancer Therapeutic Production by Player (2014-2019) Table Global Prostate Cancer Therapeutic Production Share by Player (2014-2019) Figure Global Prostate Cancer Therapeutic Production Share by Player in 2018 Table Prostate Cancer Therapeutic Revenue by Player (2014-2019) Table Prostate Cancer Therapeutic Revenue Market Share by Player (2014-2019) Table Prostate Cancer Therapeutic Price by Player (2014-2019) Table Prostate Cancer Therapeutic Manufacturing Base Distribution and Sales Area by Player Table Prostate Cancer Therapeutic Product Type by Player Table Mergers & Acquisitions, Expansion Plans Table OSI Pharmaceuticals, Inc. (USA) Profile Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Bristol-Myers Squibb Company (USA) Profile Table Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Novartis AG (Switzerland) Profile Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table GlaxoSmithKline Plc (UK) Profile Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Indevus Pharmaceuticals Inc. (USA) Profile Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Paladin Labs Inc. (Canada) Profile Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Cell Genesys Inc. (USA) Profile Table Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Abbott Laboratories (USA) Profile Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Sanofi-Aventis SA (France) Profile Table Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Pfizer Inc. (USA) Profile Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Immunomedics, Inc. (USA) Profile Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Genentech Inc. (USA) Profile Table Genentech Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Progenics Pharmaceuticals, Inc. (USA) Profile Table Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table ALZA Corporation (USA) Profile Table ALZA Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Takeda Pharmaceutical Company Limited (Japan) Profile Table Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile Table F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Medimmune, LLC (USA) Profile Table Medimmune, LLC (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table EUSA Pharma, (USA) Inc. (USA) Profile Table EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table AstraZeneca PLC (UK) Profile Table AstraZeneca PLC (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Amgen Inc. (USA) Profile Table Amgen Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Dendreon Corporation (USA) Profile Table Dendreon Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Spectrum Pharmaceuticals, Inc. (USA) Profile Table Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Global Prostate Cancer Therapeutic Production by Type (2014-2019) Table Global Prostate Cancer Therapeutic Production Market Share by Type (2014-2019) Figure Global Prostate Cancer Therapeutic Production Market Share by Type in 2018 Table Global Prostate Cancer Therapeutic Revenue by Type (2014-2019) Table Global Prostate Cancer Therapeutic Revenue Market Share by Type (2014-2019) Figure Global Prostate Cancer Therapeutic Revenue Market Share by Type in 2018 Table Prostate Cancer Therapeutic Price by Type (2014-2019) Figure Global Prostate Cancer Therapeutic Production Growth Rate of Type 1 (2014-2019) Figure Global Prostate Cancer Therapeutic Production Growth Rate of Type 2 (2014-2019) Figure Global Prostate Cancer Therapeutic Production Growth Rate of Type 3 (2014-2019) Table Global Prostate Cancer Therapeutic Consumption by Application (2014-2019) Table Global Prostate Cancer Therapeutic Consumption Market Share by Application (2014-2019) Table Global Prostate Cancer Therapeutic Consumption of Application 1 (2014-2019) Table Global Prostate Cancer Therapeutic Consumption of Application 2 (2014-2019) Table Global Prostate Cancer Therapeutic Consumption of Application 3 (2014-2019) Table Global Prostate Cancer Therapeutic Consumption by Region (2014-2019) Table Global Prostate Cancer Therapeutic Consumption Market Share by Region (2014-2019) Table United States Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Europe Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table China Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Japan Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table India Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Central and South America Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Middle East and Africa Prostate Cancer Therapeutic Production, Consumption, Export, Import (2014-2019) Table Global Prostate Cancer Therapeutic Production by Region (2014-2019) Table Global Prostate Cancer Therapeutic Production Market Share by Region (2014-2019) Figure Global Prostate Cancer Therapeutic Production Market Share by Region (2014-2019) Figure Global Prostate Cancer Therapeutic Production Market Share by Region in 2018 Table Global Prostate Cancer Therapeutic Revenue by Region (2014-2019) Table Global Prostate Cancer Therapeutic Revenue Market Share by Region (2014-2019) Figure Global Prostate Cancer Therapeutic Revenue Market Share by Region (2014-2019) Figure Global Prostate Cancer Therapeutic Revenue Market Share by Region in 2018 Table Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table United States Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Central and South America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Middle East and Africa Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2014-2019) Table Key Raw Materials Introduction of Prostate Cancer Therapeutic Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Market Concentration Rate of Raw Materials Figure Manufacturing Cost Structure Analysis Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic Figure Prostate Cancer Therapeutic Industrial Chain Analysis Table Raw Materials Sources of Prostate Cancer Therapeutic Major Players in 2018 Table Downstream Buyers Figure Global Prostate Cancer Therapeutic Production and Growth Rate Forecast (2019-2026) Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2019-2026) Figure Global Prostate Cancer Therapeutic Price and Trend Forecast (2019-2026) Table United States Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Europe Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table China Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Japan Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table India Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Middle East and Africa Prostate Cancer Therapeutic Production, Consumption, Export and Import Forecast (2019-2026) Table Global Prostate Cancer Therapeutic Market Production Forecast, by Type Table Global Prostate Cancer Therapeutic Production Volume Market Share Forecast, by Type Table Global Prostate Cancer Therapeutic Market Revenue Forecast, by Type Table Global Prostate Cancer Therapeutic Revenue Market Share Forecast, by Type Table Global Prostate Cancer Therapeutic Price Forecast, by Type Table Global Prostate Cancer Therapeutic Market Production Forecast, by Application Table Global Prostate Cancer Therapeutic Production Volume Market Share Forecast, by Application Table Global Prostate Cancer Therapeutic Market Revenue Forecast, by Application Table Global Prostate Cancer Therapeutic Revenue Market Share Forecast, by Application Table Global Prostate Cancer Therapeutic Price Forecast, by Application